Graves' Disease Clinical Trial
Official title:
Bio-psycho-social Correlates of Psychological Distress in Patients With Graves' Disease in Euthyroid Status
Observe the relationship between thyroid function and personality traits
Thyrotoxicosis was the biochemical and physiological manifestations of excess thyroid
hormone. The clinical manifestation was palpitation, heat intolerance, hand tremor, and
weight loss. The clinical manifestation also included nervous system, including anxiety,
tension, irritability, hyperactivity, fatigue, and insomnia.
Where tensions features include restless, short attention span, and the impulse to want to
move around. Some patients will progress to a non-specific psychiatric disorders. According
to the study, about 10% of patients will occur very frank psychosis, 3, 31% to 69% of
patients with depressive symptoms, 61% to 62% of patients with symptoms of anxiety.
Some studies using reliable evaluation tool to evaluate behavioral changes in patients with
thyrotoxicosis, such as Clyde emotional scale, multi-faceted personality assessment table
(Multiphasic Personality Inventory (MMPI)), or observation of a response time to visual or
audio stimulation. After treatment of thyrotoxicosis, most of these indicators have
improved, but some indicators were still abnormal after treatment of thyrotoxicosis, such as
MMPI and voice response time.
The physiological causes of the changes of these nervous system is not clear. The symptoms
was improved after the use of sympathetic inhibitors, so presumably this may correlated with
autonomic nervous system disorders.
Thyroid hormone receptors are widely distributed in the brain may also be one of the cause.
But there still some other reasons for the changes of neurological symptoms because
neurological symptoms may not be back to normal even after thyroid function returned to
normal. Autoimmune dysfunction affect brain function may be the most possible reason.
Graves' disease is the most common cause of thyrotoxicosis and it is related to autoimmune
thyroid antibodies.
Clinically, some patients of Graves' disease may combined with other autoimmune disease,
such as Sicca syndrome. The patient may still have nervous personality traits despite
normalized thyroid function. Some patients even need long-term use of anti-anxiety
medication.
In this study, investigators hope to analyze the personality traits of patients with
hyperthyroidism,especially patients of Graves' disease, in Taiwan and to observe the changes
during treatment. Investigators also hope to observe the statistical change of other
non-thyroid-specific autoimmune index in this thyrotoxicosis patient. After obtaining these
results, investigators will evaluate whether to continue to study the hypothesis of
affection of brain of thyrotoxic patients by the abnormal autoimmune system.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01950260 -
Early Levothyroxine Post Radioactive Iodine
|
Phase 2/Phase 3 | |
Completed |
NCT01269749 -
Radioactive Iodide Therapy for Pediatric Graves' Disease
|
Phase 2 | |
Recruiting |
NCT06068179 -
Graves' Disease Remission Study: MycoMeth Combo
|
Phase 2/Phase 3 | |
Recruiting |
NCT02114619 -
Comparative Study of Different I-131 Doses in Graves' Disease
|
N/A | |
Completed |
NCT04383795 -
Change of Gut Microbiome in the Treatment of Graves' Disease
|
||
Completed |
NCT02384668 -
D-vitamin And Graves' Disease; Morbidity And Relapse Reduction
|
N/A | |
Completed |
NCT01885533 -
Post-Radioiodine Graves' Management: The PRAGMA-Study
|
N/A | |
Completed |
NCT01534169 -
Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients
|
Phase 1 | |
Completed |
NCT00917241 -
Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone
|
Phase 4 | |
Completed |
NCT00004660 -
Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
|
N/A | |
Completed |
NCT02205801 -
Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy
|
N/A | |
Completed |
NCT00958113 -
Autoimmune Thyroid Disease Genetic Study
|
N/A | |
Completed |
NCT02727738 -
Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole
|
N/A | |
Completed |
NCT00697528 -
Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy
|
N/A | |
Completed |
NCT00150124 -
Block-replacement Therapy During Radioiodine Therapy
|
Phase 4 | |
Completed |
NCT03535090 -
Coagulation After Intravenous Methylprednisolone Administration
|
||
Not yet recruiting |
NCT02373995 -
Role of the Microbiome in Graves' Orbitopathy
|
Phase 1/Phase 2 | |
Completed |
NCT00505011 -
Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves’ Disease
|
N/A | |
Completed |
NCT02107794 -
Shared Decision Making in Graves Disease - Graves Disease (GD) Choice
|
N/A | |
Recruiting |
NCT01182584 -
Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease
|
N/A |